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Mast cellducts (AGEs) accumulate during aging and to higher extents under pathological
conditions such as diabetes. Since we previously showed that mast cells expressed the AGE-binding protein,
receptor for AGEs (RAGE) on their cell surface, we examined whether AGE affected mast cell survival. Herein,
we demonstrate that mast cells undergo apoptosis in response to AGE. Glycated albumin (GA), an AGE, but
not stimulation with the high-afﬁnity IgE receptor (FcɛRI), can induce mast cell death, as measured by
annexin V/propidium iodide double-staining. GA (≥0.1 mg/ml) exhibited this pro-apoptotic activity in a
concentration-dependent manner. GA and FcɛRI stimulation increased the cytosolic Ca2+ levels to a similar
extent, whereas GA, but not FcɛRI stimulation, caused mitochondrial Ca2+ overload and membrane potential
collapse, resulting in mitochondrial integrity disruption, cytochrome c release and caspase-3/7 activation. In
addition, GA, but not FcɛRI stimulation, induced extracellular release of superoxide from mitochondria, and
this release played a key role in the disruption of Ca2+ homeostasis. Knockdown of RAGE expression using
small interfering RNA abolished GA-induced apoptosis, mitochondrial Ca2+ overload, and superoxide release,
demonstrating that RAGE mediates the GA-induced mitochondrial death pathway. AGE-induced mast cell
apoptosis may contribute to the immunocompromised and inﬂammatory conditions.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Advanced glycation end products (AGEs) are formed by non-
enzymatic reactions between carbonyl groups of reducing sugars and
free amino groups of macromolecules such as proteins, lipoproteins
and nucleic acids [1–3]. This heterogeneous group of glycated
structures is found in the plasma and accumulates in vessel walls
and tissues during aging and at an accelerated rate in diabetes [4,5].
AGE formation is considered to be one of the major etiologic factors in
aging- and diabetes-related chronic inﬂammatory diseases, by
promoting cellular dysfunction and breaking immune tolerance.
Diabetes mellitus is characterized by hyperglycemia that facilitates
AGE formation in both blood and tissues [6,7]. However, the
mechanisms by which AGEs cause cellular dysfunction are not fully
understood. One potential mechanism is through the induction of cell
death by apoptosis. AGEs are pro-apoptotic for cultured microvascular
cells, neuronal cells, ﬁbroblasts and renal mesangial cells [8–13], and
these apoptotic effects are associated with aging and diabetic
complications, such as atherosclerosis, nephropathy, neuropathy,
defective would healing and retinopathy.1 3 3972 8227.
ki).
l rights reserved.Recent studies focusing on their interactions with many cell types
have led to the isolation and characterization of a number of AGE cell
surface receptors/binding proteins. They include receptor for AGEs
(RAGE), oligosaccharyl transferase-48 (OST-48; AGE-R1), 80K-H
phosphoprotein (AGE-R2), galectin-3 (AGE-R3), and the scavenger
receptors class A type II (MSR-AII), and class B type I (MSR-BI; CD36)
[14–17]. These receptors have been shown to play distinct functional
roles in AGE toxicity as well as AGE removal. The best-characterized
receptor is RAGE [18,19], a member of immunoglobulin superfamily of
cell surface receptors that binds many ligands including those of the
S100/calgranulin family. RAGE is known to play key roles in cell
dysfunction and the mechanisms of inﬂammatory diseases through
the activation of the Ras-MAPK pathway, while some of the other
receptors may have other functions such as AGE detoxiﬁcation and
AGE removal [20–23].
Immune cells are other potential targets of AGEs, since diabetes
and aging are accompanied by altered immunological reactions. It is
widely accepted that similar to aged individuals, uncontrolled type I
diabetic patients are more susceptible to bacterial and fungal
infections than normal subjects, although the cause has not yet
been determined [24]. The higher susceptibility to and severity of
infections and the increased frequency of inﬂammatory diseases,
such as atherosclerosis and periodontitis, in diabetic and aging
individuals, suggest AGE-induced dysregulation of the immune
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superoxide (O2
U−) production, defective chemotaxis and phagocytosis
have been demonstrated in diabetic mononuclear phagocytes [25].
Oxidative stress has been shown to play a role in the pathogenesis
of diabetic complications. It has also been shown that diabetic
monocytes produce signiﬁcantly more O2
U− than non-diabetic cells in
the resting state or in response to divergent stimuli, including AGE
and S100B, and that the increased O2
U− generation is correlated with
glycated hemoglobin levels in diabetic patients [26]. On the other
hand, AGE albumin impairs human neutrophil functions including
transendothelial migration, Staphylococcus aureus-induced O2
U− gen-
eration, and bacterial killing [27]. However, the mechanisms by
which oxidative stress modulates biological effects of AGE are poorly
understood. In addition, effects of AGEs on immune cell survival are
unknown.
Mast cells play key roles in allergic and inﬂammatory responses as
well as in innate and acquired immunity [28,29]. We recently showed
that mast cells express both RAGE and galectin-3 on their cell surface
and that exogenous galectin-3 can exhibit strong pro-apoptotic
activity toward these cells via RAGE [30]. These observations suggest
that RAGE and galectin-3 are key regulators of mast cell death. To
establish this view, we examined whether exogenous AGE induced
mast cell death. In the current studywe report for the ﬁrst time that an
AGE, glycated albumin (GA) induces mast cell death by apoptosis
through binding to RAGE. Our results indicate that GA speciﬁcally
evokes mitochondrial Ca2+ ([Ca2+]m) overload, resulting in mitochon-
drial integrity disruption and the caspase-dependent cell death. We
further showed that extracellular superoxide (O2
U−) released from
mitochondria played a key role in [Ca2+]m overload.
2. Materials and methods
2.1. Materials
Bongkrekic acid dissolved in water was obtained from BioMol
(Plymouth Meeting, PA, USA). Atractyloside, thapsigargin (TG) and
superoxide dismutase (SOD) were obtained from Sigma (St. Louis,
MO, USA). Atractyloside and TG were dissolved in dimethyl sulfoxide
(DMSO) and diluted with Hank's balanced salt solution (HBSS) to a
ﬁnal concentration of b0.1% before use. At a concentration of 0.1%,
DMSO had no effects on its own throughout the present study. 2,4,6-
Trinitrophenyl (TNP)-conjugated bovine serum albumin (TNP-BSA,
TNP:BSA conjugation ratio of 25:1) was purchased from Cosmo Bio
(Tokyo, Japan). A neutralizing antibody against receptor for AGEs
(RAGE) was purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA, USA). Fluo3-acetoxyl-methyl ester (Fluo3/AM) was
obtained from Dojindo Laboratories (Kumamoto, Japan). Rhod-2-
acetoxylmethyl ester (rhod-2/AM), MitoSOX Red (MitoSOX) [3,8-
phenanthridinediamine, 5-(6′-triphenyl-phosphoniumhexyl)-5,6
dihydro-6-phenyl] and JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-
benz-imidazolocarbocyamine iodide) were purchased from Invitro-
gen Corporation (Carlsbad, CA, USA). All other chemicals were of
analytical grade.
2.2. Preparation of glycated albumin (GA)
GA were aseptically prepared by incubating 10 mg/ml BSA (RIA
grade fraction V; Sigma) with 1 M glucose in phosphate-buffered
saline (PBS) containing 0.1% NaN3 for 13 weeks at 37 °C. Control
unmodiﬁed albumin was prepared in a similar way in the absence of
glucose. The GA and unmodiﬁed albumin samples were desalted by
Sephadex G-25 (ﬁne grade; 1.8×30 cm) column gel ﬁltration with
0.05 M NH4HCO3 and freeze-dried to remove the NH4HCO3. Amino
acid analysis of aliquots of GA and unmodiﬁed albuminwas performed
using a System 6300E Amino Acid Analyzer (Beckman, Fullerton, CA)
as previously described [31]. The amino acid composition of GA weresimilar to that of unmodiﬁed albumin, except for the following amino
acids: Lys (GA, 33.2 residues; unmodiﬁed albumin, 59 residues), Arg
(GA, 13.8 residues; unmodiﬁed albumin, 23 residues) and His (GA, 14.3
residues; unmodiﬁed albumin, 17 residues). The relative electro-
phoretic mobility (Re) of GA to methylene blue was 0.78 on a cellulose
acetate membrane with Veronal buffer (pH8.6), whereas the Re of
unmodiﬁed albumin was 0.50, indicating that GA possess fewer
positive charges, consistent with the data for the amino acid analysis.
GA (4 μg/ml) but not unmodiﬁed albumin reacted with a peroxidase
conjugated anti-AGE monoclonal antibody (Wako Pure Chemicals,
Osaka, Japan). Throughout the current study, unmodiﬁed albuminwas
used as a control.
2.3. RBL-2H3 cells
RBL-2H3 cells were obtained from the National Institute of Health
Sciences (Japanese Collection of Research Bioresources (JCRB), Tokyo,
Japan; Cell number, JCRB0023) and grown in Dulbecco's modiﬁed
Eagle's medium (DMEM; Sigma) supplemented with 10% fetal bovine
serum (FBS; SAFC Biosciences, Tokyo, Japan) in a 5% CO2-containing
atmosphere. The cells were harvested by incubation in HBSS contain-
ing 1 mM ethylenediamine tetraacetate and 0.25% trypsin for 5 min at
37 °C. Cells suspended in supplemented DMEM were plated on 100-
mm culture dishes (1×107 cells/10ml) or in 6-well plates (3×106 cells/
well) and cultured at 37 °C.
2.4. Bone marrow-derived mast cells (BMMCs)
BMMCswere prepared from the femurs of 4–8-week-old C57BL/6 J
and C3HeBFeJ mice as previously described [32]. All animal experi-
ments were performed according to Nihon University guidelines. The
cells were cultured in RPMI 1640medium (Sigma) supplemented with
10% FBS, 100 U/ml penicillin (invitrogen), 100 μg/ml streptomycin
(Invitrogen), 5×10−5 M β-mercaptoethanol (Wako), 100 μg/ml sodium
pyruvate (Invitrogen), 1% minimal essential medium (MEM) nones-
sential amino acid solution (Invitrogen) and 5 ng/ml of recombinant
IL-3 (PeproTech Inc., Rocky Hill, NJ, USA) in a 5% CO2-containing
atmosphere at 37 °C. After 4–6 weeks of culture, the cells were stained
for their cell surface expression of FcɛRI. BMMCs were used for
experiments after 4–8 weeks of culture (N95% mast cells).
2.5. HMC-1 cells
HMC-1 cells (a human mast cell line) were cultured in Iscove's
modiﬁed Dulbecco's medium (IMDM; Invitrogen) supplemented with
10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin in a 5% CO2-
containing atmosphere as previously described [33].
2.6. Evaluation of cell death
Apoptotic cell death and overall cell death were evaluated by
double-staining with ﬂuorescein isothiocyanate (FITC)-conjugated
annexin V and propidium iodide (PI) as previously described [30].
Brieﬂy, cells adhered to 24-well plates (5×105 cells/well) were treated
with the inhibitor tested in 10% FBS/DMEM and then stimulated with
GA, TNP-BSA, or TG for 18–22 h. Next, phosphatidylserine that
translocated from the inner leaﬂet of the plasma membrane to the
outer leaﬂet was detected by annexin V staining using a commercially
available kit (Annexin V FITC Apoptosis Detection Kit I; BD PharMin-
gen, San Diego, CA, USA), according to themanufacturer's instructions.
By double-staining the cellswith annexinV-FITC andPI, subsets of cells
thatwere annexinV-positive and PI-negative (apoptotic) or annexinV-
positive and PI-positive (necrotic and/or cells in advanced apoptosis)
were determined. Double-negative cells were considered to be living
cells. The stained cells were evaluated in a FACSCalibur and analyzed
using the CellQuest software (Becton-Dickinson, San Jose, CA, USA).
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Call surface expression of RAGE was determined by ﬂow
cytometry as previously described [30]. RBL-2H3 cells or BMMCs
(5×105 cells/20 μl) were incubated with anti-RAGE antibody for
30 min at 4 °C. The cells were then centrifuged into a pellet,
resuspended in PBS and incubated with FITC-conjugated anti-goat IgG
(Santa Cruz Biotechnology) for 30 min at 4 °C. The expression of RAGE
on these cells was evaluated in a FACSCalibur and analyzed using the
CellQuest software.
2.8. Measurement of [Ca2+]i
The cytosolic Ca2+ concentration ([Ca2+]i) was measured using the
Ca2+-reactive ﬂuorescent probe Fluo3/AM as previously described
[34]. Brieﬂy, a cell suspension (1×106 cells/ml) was incubated with
4 μM Fluo3/AM for 30 min at 37 °C, washed with HBSS, and
resuspended in Ca2+-containing medium (HBSS supplemented with
1 mM CaCl2) or Ca2+-free medium (HBSS supplemented with 1 mM
ethylene glycol tetraacetic acid (EGTA) instead of 1 mM CaCl2).
Fluorescence was monitored at 5-s intervals for up to 3 min using a
microplate ﬂuorometer (Fluoroskan Ascent CF; Labsystems, Helsinki,
Finland) with excitation and emission at 485 nm and 527 nm,
respectively.
2.9. Measurement of [Ca2+]m
The mitochondrial Ca2+ concentration ([Ca2+]m) was measured
using the mitochondria-localizing Ca2+-reactive ﬂuorescence probe
rhod-2/AM as previously described [36]. Brieﬂy, to improve the
discrimination between cytosolic and mitochondria-localized dye
[35], 5 μM rhod-2/AM was reduced to the colorless nonﬂuorescent
dihydrorhod-2/AM by sodium borohydride according to the manu-
facturer's protocol. A cell suspension (1×106 cells/ml) was incubated
with the dye for 30 min at 37 °C, washed with HBSS and resuspended
in HBSS supplemented with 1 mM CaCl2. After stimulation of the
cells, ﬂuorescence was monitored at 5-s intervals for up to 3 min
using the above described microplate ﬂuorometer with excitation
and emission at 544 nm and 590 nm, using 5 μM A23187 and 5 μM
A23187 plus 10 mM EGTA, respectively, as positive and negative
controls.
2.10. Cytochrome c release assay
Cytochrome c release was measured as previously described [30].
Brieﬂy, cells adhered to 6-well plates (3×106 cells/well) were washed,
treated with the inhibitor tested in 10% FBS/DMEM and stimulated
with GA for 18 h. To assess the cytochrome c content in the
mitochondria, the cells were fractionated into mitochondrial and
cytosolic fractions by differential centrifugation using a mitochondria
isolation kit (Pierce, Rockford, IL), and the mitochondrial fraction was
lysed with 1% Triton X-100. The cytochrome c content in each fraction
was determined using a commercially available a solid-phase
sandwich ELISA kit (Cytochrome c, Mouse/Rat, ELISA Kit, Quantikine
M®, R&D Systems) according to the manufacturer's protocol.
2.11. Measurement of mitochondrial transmembrane potential (ΔΨm)
with JC-1
Changes in the mitochondrial transmembrane potential (ΔΨm)
were measured using the lipophilic cation JC-1 as described
previously [34]. Cells (5×105/500 μl) were loaded with 2 μM JC-1 for
15min in a CO2 incubator, washed, and resuspended in HBSS. After cell
stimulation, the green ﬂuorescence (the monomeric JC-1) and red
ﬂuorescence (J-aggregates) were measured using the FL-1 and FL-2
channels, respectively, with a FACSCalibur (Bectone-Dickinson).2.12. Caspase-3/7 activation and mitochondrial membrane
potential measurements
Caspase-3/7 activation and mitochondrial membrane potential
were evaluated as previously described [30]. Brieﬂy, cells adhered to
24-well plates (5×105 cells/well) were treated with the inhibitor
tested in 10% FBS/DMEM and then stimulated with GA for 18 h.
Caspase-3/7 activation and changes in the mitochondrial membrane
potential were determined using a Dual Sensor: MitoCasp™ (Cell
Technology Inc., Mountain View, CA), according to the manufac-
turer's protocol. Stained cells were evaluated in a FACSCalibur and
analyzed using the CellQuest software.
2.13. O2
U− production assay
O2
U− production was measured using a SOD-inhibitable cyto-
chrome c reduction assay as previously described [32]. Brieﬂy,
RBL-2H3 cells (1×106 cells/ml) were stimulated with GA, and
20 μM cytochrome c was added. The reduction in absorbance at
540 nm (ΔOD540) was measured immediately in a Model 550
Microplate Reader (Nippon Bio-Rad Laboratories, Osaka, Japan). To
measure the SOD-dependent responses, SOD was added to the
reaction mixture in separate samples at a ﬁnal concentration of 10
U/ml, and the reduction in absorbance at 540 nm (ΔOD540 [SOD])
was measured in the same way. The data are shown as SOD-
inhibitable cytochrome c reduction, corresponding to ΔOD540–ΔOD540
[SOD].
Mitochondrial O2
U− generation was measured using the mitochon-
dria-targeting probe MitoSOX Red as previously described [36]. RBL-
2H3 cells (1×106 cells/ml) were incubated with 5 μM MitoSOX Red
for 15 min at 37 °C in a ﬁnal volume of 450 μl. Then 50 μl of
stimulants (10×) was added and incubated at 37 °C for the time
indicated before harvest. Cells were then washed, resuspended in
HBSS on ice, centrifuged at 4 °C. After stimulation, the red
ﬂuorescence was measured using the FL-2 channel, with a
FACScalibur (Becton Dickinson). In inhibition experiments, the
agents tested were added to cells just before stimulation.
2.14. RT-PCR
Total RNA was isolated from 1×106 cells using ISOGEN
(Nippon Gene Corporation, Tokyo, Japan) and reverse transcribed
to cDNA using SuperScript™ II reverse transcriptase (invitorogen),
oligo dT primer (Invitrogen) and 0.5 mM dNTP Mixture (Invitro-
gen). RAGE and GAPDH mRNA were measured by RT-PCR using a
Model PC-802 thermal cycler (Astec Corporation, Fukuoka, Japan).
Primers were for RAGE, 5′-CTACCTATTCCTGCAGCTTC-3′ and 5′-
CTGATGTTGACAGGAGGGCTTTCC-3′; for GAPDH: 5′-ACCACAGTC-
CATGCCATCAC and 5′-TCCACCACCCTGTTGCTGTA-3′. The PCR was
performed for 30 cycles, each consisting of 1 min at 95 °C for
denaturation, 1 min at 60 °C for annealing and 1 min at 72 °C for
extension.
2.15. siRNA knockdown of RAGE expression
The target siRNA for RAGE and a negative control siRNA with
an irrelevant sequence were purchased from Ambion (Austin,
Texas, USA). Adherent cells plated in 6-well plates (2.5×105 cells/
well) or in 24-well plates (5.0×104 cells/well) were transfected
for 48 h with RAGE siRNA (ﬁnal concentration, 5 nM) using
siPORT™ NeoFX trasfection agent (Ambion), according to the
manufacture's instruction. The efﬁcacy of knockdown for RAGE
gene expression was evaluated using RT-PCR analysis as described
above. Transfected cells were then treated with GA, and apoptotic
cell death, [Ca2+]m levels, and O2
U− production were assessed as
described above.
Fig. 1.Mast cells undergo apoptosis upon exposure to GA. (A) RBL-2H3 cells adhered to 24-well plates (5×105 cells/200 μl) were stimulatedwith GA at the indicated concentrations (d–
f), 1mg/ml albumin (b) or 1 μMTG (c) for 18 h at 37 °C, and then harvested. (B) BMMCs and HMC-1 cells suspended in 24-well plates (5×105 cells/200 μl) were stimulatedwith 0.3 mg/
ml GA or 1mg/ml albumin for 18 h at 37 °C. Cells were then stainedwith FITC-conjugated annexin V and PI, and analyzed byﬂowcytometry. Double-negative cells are considered to be
living cells. The data are representative of at least four independent experiments. The statistical signiﬁcance was determined using an unpaired Student's t-test. ***pb0.001.
Fig. 2. Mast cells express RAGE on their cell surface. RBL-2H3 cells or BMMCs in PBS
(5×105 cells/20 μl) were stained with anti-RAGE antibody, and the expression of each
molecule on the cells was evaluated by ﬂow cytometry. The ﬁlled histograms represent
speciﬁc staining and the solid lines represent the non-stained controls. The data are the
representative of three independent experiments.
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Student's t-test was used to determine the statistical signiﬁcance of
differences among the experimental groups. Values of pb0.05 were
considered signiﬁcant.
3. Results
3.1. GA induces mast cell apoptosis
First, we tested the ability of GA to induce cell death. Adherent
RBL-2H3 cells in serum-containing medium were exposed to varying
concentrations of GA or 1 μM TG (positive control) for 18–22 h, and
phosphatidylserine exposure and PI permeability were analyzed by
ﬂow cytometry. Clear increases in the annexin V- and/or PI-positive
cell populations were observed for GA-treated cells compared with
vehicle- (Fig. 1A, panel a) or unmodiﬁed albumin-treated control
cells (Fig. 1A, panel b), indicating that GA can induce cell death by
both apoptosis and non-apoptosis/necrosis. GA exhibited this pro-
apoptotic activity in a concentration-dependent manner with a
minimum effective concentration of 0.1 mg/ml (Fig. 1A, panels d–f).
The percent annexin V-positive populations indicative of apoptotic
cells for vehicle- and 0.3 mg/ml GA-treated cells were 4.4±0.9% and
49.5±5.2%, respectively (n=7). To exclude the possibility that the
induction of apoptosis was an aberrant special case for tumor mastcells like RBL-2H3, we tested the effects of GA on BMMC survival.
BMMCs prepared from two different strains of mice (C57BL/6 J and
C3HeBFeJ) were examined for their susceptibility to apoptosis after
treatment with GA for 18 h. Both BMMCs displayed sizable apoptosis,
Fig. 3. GA elicits a pro-apoptotic effect through binding to a putative surface receptor via RAGE. (A) RBL-2H3 cells (5×105 cells/200 μl) were incubatedwith 0.3 mg/ml GA (b, c) or 1 μM
TG (d, e) for 18 h at 37 °C in the presence of 1 μg/ml anti-RAGE antibody (c, e), and cell death was analyzed by annexin V/PI double-staining. (B) Summarized data of the percentages of
the annexin V-positive cell populations relative to the where whole cell population set at 100%. The data represent the mean±SE of ﬁve independent experiments. The statistical
signiﬁcance was determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001.
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Furthermore, we obtained essentially similar results with the human
mast cell line, HMC-1 (Fig. 1B). On the other hand, unmodiﬁed
albumin had no cytotoxicity at concentrations up to 1 mg/ml.
Collectively, these results demonstrate that GA provokes mast cell
death by apoptosis.
3.2. Expression of RAGE on mast cells
Since AGEs are a heterogeneous group of glycosylated proteins, the
actions of AGEs are mediated by various receptors. RAGE, a member of
the immunoglobulin superfamily, is the best-characterized cellular
receptor for AGEs [18,19]. Similar to those used in our previous study
[30], ﬂow cytometric analyses showed that both the RBL-2H3 cells and
the BMMCs used throughout the present study clearly expressed
RAGE on their cell surfaces (Fig. 2).
3.3. GA-induced apoptosis is mediated by RAGE
Since RBL-2H3 cells were more susceptible to GA-induced
apoptosis than BMMCs and HMC-1 cells, we analyzed the GA-induced
apoptosis in more detail using RBL-2H3 cells. We initially elucidated
the roles of RAGE in the pro-apoptotic activity of GA by using blocking
antibodies against the molecule. The anti-RAGE antibody completely
blocked GA-induced apoptosis (Fig. 3A, panel c). On the other hand,
this blocking antibody had a minimal effect on TG-induced apoptosis
(Fig. 3A, panel e). Fig. 3B shows a statistical analysis of the data for cells
treatedwith 0.3mg/ml GA for 18 h. Taken together, these data indicate
that GA induce mast cell death through binding to putative surface
receptor including RAGE.
3.4. GA induces a Ca2+ ﬂux and mitochondrial Ca2+ overload via RAGE
Since Ca2+ is thought to be an important mediator of cell death,
we next examined whether GA could affect Ca2+ signaling. RBL-2H3
cells preloaded with the Ca2+-sensitive ﬂuorescent dye Fluo3/AM
were treated with varying concentrations of GA, and ﬂuorescencewas measured for 3 min using a microplate ﬂuorescence reader. GA
induced a concentration-dependent increase in [Ca2+]i with a
minimum effective concentration of 0.1 mg/ml (Fig. 4A), whereas
unmodiﬁed albumin had no effect at concentrations up to 1 mg/ml.
The amplitude of the increase was comparable to that observed
upon stimulation with TNP-BSA (FcɛRI stimulation), although GA,
but not TNP-BSA induced substantial cell death (see Fig. 5B). Thus,
GA can induce Ca2+ mobilization and apoptosis at comparable
concentrations. The effect was still observed for cells presensitized
with IgE, indicating that this effect is independent of FcɛRI (data not
shown). The GA-induced Ca2+ ﬂux was substantially reduced but
still observed in nominally Ca2+-free medium (in the presence of
1 mM EGTA; Fig. 4B), suggesting that GA stimulates Ca2+ mobiliza-
tion mainly from intracellular stores and to a lesser extent, from the
extracellular milieu. Furthermore, the anti-RAGE antibody substan-
tially reduced GA-induced Ca2+ ﬂux (Fig. 4C). We also measured
mitochondrial Ca2+ ([Ca2+]m) using the mitochondrial membrane
potential (ΔΨm)-dependent Ca2+-sensitive ﬂuorescent dye rhod-2/
AM. GA caused a concentration-dependent increase in [Ca2+]m,
which was observed immediately after stimulation (Fig. 5A).
Moreover, even at the minimum effective concentration (0.1 mg/
ml), the effect of GA was higher than that of TNP-BSA stimulation,
which had a minimal effect on cell survival (Fig. 5B). In addition,
blocking antibodies against RAGE blocked GA-induced apoptosis
(see Fig. 3), reduced the [Ca2+]m increase comparable to that seen
after TNP-BSA stimulation (Fig. 5C). These results indicate that GA
evokes an extensive [Ca2+]m load via RAGE, which may play a role in
GA-induced apoptosis.
3.5. GA induces apoptosis in a permeability transition pore
(PTP)-dependent manner
We recently reported that exogenesis galectin-3 evokes mast cell
death through a mitochondrial PTP-dependent pathway [30]. We
therefore examined whether GA also utilize similar death pathway.
As shown in Fig. 6, the PTP antagonist bongkrekic acid completely
blocked GA-induced cell death (Fig. 6A, panel c), whereas the PTP
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death, although it increased the necrotic cell (annexin V- and PI-
positive) population and decreased the apoptotic (annexin V-positive
but PI-negative) population (Fig. 6A, panel d). In contrast, the two
agents had no effect on TG-induced cell death (Fig. 6B). These results
indicate that GA, but not TG, induces mast cell death in a PTP-
dependent manner.
3.6. GA induces mitochondrial cytochrome c release, caspase-3/7
activation and mitochondrial membrane potential reduction in a
PTP-dependent manner
Mitochondria are now recognized to act as central gateway
controllers in the cell death pathway through their release of various
pro-apoptotic substances, including cytochrome c, into the cytoplasm,
which stimulate the caspase-dependent death pathway. Moreover,
PTPs are thought to be the principal route of cytochrome c release. WeFig. 5. GA induces mitochondrial Ca2+ overload via RAGE. (A) RBL-2H3 cells (1×106
cells/ml) were incubated with 5 μM rhod-2/AM at 37 °C for 30min and thenwashed with
HBSS. The rhod2-loaded cells were stimulated with GA at the indicated concentrations or
30 ng/ml TNP-BSA. Fluorescence was monitored for up to 3 min in a microplate
ﬂuorometer. (B) RBL-2H3 cells grown in24-well plates (5×105 cells/200 μl)were incubated
with 0.3 mg/ml GA or 30 ng/ml TNP-BSA for 18 h at 37 °C, and cell death was analyzed by
annexin V/PI double-staining. The data were calculated as the percentages of annexin V-
positive cell populations relative to thewhole cell population set at 100%, and represent the
mean±SE of six independent experiments. The statistical signiﬁcance of differences versus
GA stimulation alone was determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001. (C)
The rhod2-loaded cells were stimulated with 0.3 mg/ml GA in the presence or absence of
1 μg/ml anti-RAGE antibody. Fluorescence was monitored for up to 3 min in a microplate
ﬂuorometer. These data shown as [Ca2+]m are representative of at least ﬁve independent
experiments.
Fig. 4. GA induces a Ca2+ inﬂux via RAGE. (A–C) RBL-2H3 cells (1×106 cells/ml) were
incubated with 4 μM ﬂuo3/AM at 37 °C for 30 min and then washed with HBSS. The
ﬂuo3-loaded cells were suspended in (A) Ca2+-containingmedium (HBSS supplemented
with 1 mM CaCl2) or (B) Ca2+-free medium (HBSS supplemented with 1 mM EGTA
instead of 1mMCaCl2), and stimulatedwith GA at the indicated concentrations or 1mg/
ml albumin. In (C), the cells suspended in Ca2+-containing medium were treated with
1 μg/ml anti-RAGE antibody, and then immediately stimulated with 0.3 mg/ml GA.
Fluorescence was monitored for up to 3 min in a microplate ﬂuorometer. The data
shown as [Ca2+]i (nM) are representative of at least ﬁve independent experiments.therefore determined whether GA affected the mitochondrial integ-
rity. GA caused a substantial increase in the cytosolic cytochrome c
content and decrease in the mitochondrial cytochrome c content (Fig.
7A and B), indicating induction of cytochrome c release. This release
was signiﬁcantly reduced by preincubating the cells with antibodies
against RAGE. Moreover, bongkrekic acid signiﬁcantly inhibited GA-
induced cytochrome c release, while atractyloside had a marginal
effect (Fig. 7B). Cytochrome c released into the cytosol forms
multimeric complexes with apoptotic protease factor-1 and pro-
caspase-9 leading to the activation of caspase-9 and downstream
caspases such as caspase-3/7, which play critical roles in the apoptotic
cascade. In addition, the collapse ofΔΨm is an important characteristic
of cell death. We therefore examined the effects of GA on these events.
Fig. 6. GA induces apoptosis in a PTP-dependent manner. (A, B) RBL-2H3 cells (5×105 cells/200 μl) were incubated with 0.3 mg/ml GA (A, b–d) or 1 μM TG (B, b–d) for 18 h at 37 °C in
the presence of 1 μM bongkrekic acid (BKA, c) or 10 μM atractyloside (ATR, d). Cell death was analyzed by annexin V/PI double-staining. The data are representative of at least three
independent experiments.
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ΔΨm using JC-1. Treatment with GA and antimycin (the selective
inhibitor for complex III of the electron transport chain) caused almost
complete loss of ΔΨm (∼20% and N95% decrease, respectively),
whereas TNP-BSA and NOR-3 (nitric oxide donor) had no such effect
(Fig. 7C). As shown in Fig. 7D, GA but not TNP-BSA, also induced
caspase-3/7 activation, and these effects were blocked by bongkrekic
acid and marginally enhanced by atractyloside. These data indicate
that GA induces mitochondrial integrity collapse and caspase activa-
tion in a PTP-dependent manner.
3.7. GA, but not FcɛRI stimulation, stimulates O2
U− release
from mitochondria
Reactive oxygen species (ROS) are intimately associated with both
apoptotic and non-apoptotic/necrotic cell death. We previously
showed that galectn-3-induced mast cell apoptosis was preceded by
production and release of O2
U− into the extracellular ﬂuid [30]. We
therefore examined whether GA induced O2
U− production in mast cells.
As shown in Fig. 8A, GA induced substantial O2
U− release into the
extracellular ﬂuid, as evidenced by the SOD-inhibitable reduction of
cytochrome c. This O2
U− release was seen immediately, reached its
maximum within a few minutes, and remained at that level for up to
5 min. The kinetics and the amplitude were similar to those observed
upon TNP-BSA stimulation (Fig. 8B). We recently demonstrated that
both a NADPH oxidase and mitochondria were involved in ROS
production in mast cells and their proinﬂammatory responses [36].
Therefore, we next tested the roles of NADPH oxidase and mitochon-
dria in GA-induced O2
U− release. Apocynin acts as a NADPH oxidase-
speciﬁc inhibitor, since it blocks the assembly of the membrane-
associated ﬂavocytochrome gp91phox with regulatory subunit p47phox
and p67phox [37,38]. Apocynin marginally reduced GA-induced O2
U−
release (Fig. 8A and C), whereas it substantially inhibited TNP-BSA-
induced O2
U− release (Fig. 8B andD). On the other hand, bongkrekic acid
strongly reduced GA-induced O2
U− release (Fig. 8A and C), whereas it
had a minimal effect on TNP-BSA-induced O2
U− release (Fig. 8B and D).
These results suggested that GA, but not TNP-BSA stimulation, inducedO2
U− release in a PTP-dependent manner. To examine this further, we
directly measured mitochondrial O2
U− levels using MitoSOX, a ﬂuorop-
robe for selective detection of O2
U− in the mitochondria [39,40]. As
shown in Fig. 9A and B, substantial increases in ﬂuorescence intensity
of MitoSOX were reproducibly observed after TNP-BSA stimulation,
whereas the MitoSOX signal was usually decreased after GA exposure.
Moreover, we found that pretreatment of the cells with BKA abolished
GA-induced decrease in the MitoSOX signal, and apocynin had a lesser
effect (Fig. 9A). On the other hand, BKA exhibited a minimal effect on
TNP-BSA-induced increase in MitoSOX signal (Fig. 9B). Collectively,
these results demonstrate that GA, but not TNP-BSA stimulation,
stimulates O2
U− release from the mitochondria.
3.8. Extracellular O2
U− mediates GA-induced apoptosis and mitochondrial
Ca2+ dysregulation
We previously showed that exogenous SOD, a cell-impermeable
O2
U−-scavenging enzyme completely protected mast cells from
galectin-3-induced apoptosis, which was blocked by anti-RAGE
antibody [30]. These observations suggest that O2
U− plays key roles
in RAGE-mediated cell death. To clarify the roles further, we
examined the effects of exogenous SOD on GA-induced cell death.
As shown in Fig. 10A, exogenous SOD completely blocked GA-induced
cell death. Moreover, SOD signiﬁcantly suppressed all of the GA-
induced cytochrome c release, caspase-3/7 activation, and decrease
in ΔΨm (Fig. 10B and C). In addition, SOD reduced GA-induced [Ca2+]m
loading to a level near to that observed upon TNP-BSA stimulation
(Fig. 10D). Taken together, these data indicate that extracellular O2
U−
mediates GA-induced mitochondrial Ca2+ dysregulation and cell
death.
3.9. RAGE mediates GA-induced mitochondrial death pathway
To demonstrate the role of RAGE in GA-induced mast cell
apoptosis more directly, we examined the effects of knocking down
RAGE expression on the apoptosis. As shown in Fig. 11A, by using
siRNA we succeeded in knocking down the expression of RAGE
Fig. 7. GA induces disruption of mitochondrial integrity and caspase activation in a PTP-dependent manner. (A, B) RBL-2H3 cells (3×106 cells/ml) were (A) stimulated with 0.3 mg/ml
GA for 18 h at 37 °C in the presence or absence of 1 μg/ml anti-RAGE antibody or (B) treated with 1 μM bongkrekic acid (BKA) or 10 μM atractyloside (ATR) and then immediately
stimulated with 0.3 mg/ml GA. The cells were fractionated into mitochondrial and cytosolic fractions by differential centrifugation, and the cytochrome c content in each fractionwas
determined using an ELISA kit. The data represent themean±SE of ﬁve independent experiments. The statistical signiﬁcance of differences versus GA stimulation in each fractionwas
determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001. (C) RBL-2H3 cells (5×105 cells/500 μl) were loaded with JC-1, and the JC-1-loaded cells suspended in Ca2+-containing
mediumwere treated with 30 ng/ml TNP-BSA, 0.3 mg/ml GA, 100 μMNOR-3 (NOR), or 5 μg/ml antimycin A (AM) for 18 h. The green and red dye ﬂuorescence was then measured by
ﬂow cytometry. The data are shown as percentages of the basal level and represent the mean±SE of three independent experiments. The statistical signiﬁcance of differences versus
untreated control was determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001. (D) RBL-2H3 cells (4×105 cells/well) were stimulated with 0.3 mg/ml GA or 30 ng/ml TNP-BSA at
37 °C in the presence or absence of 1 μM BKA or 10 μM ATR. Subsequently, caspase-3/7 activation and changes in the mitochondrial membrane potential were determined by ﬂow
cytometry. The data are representative of at least three independent experiments.
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undergo apoptosis in response to GA (Fig. 11B). Moreover, we
observed that in the RAGE knocked down cells GA had minimaleffects on O2
U− production and [Ca2+]m overload (Fig. 11C and D). These
data clearly demonstrate that RAGE mediates GA-induced mitochon-
drial death pathway.
Fig. 8. GA, but not TNP-BSA stimulation, induces O2
U− release in a PTP-dependent manner. (A, B) RBL-2H3 cells (1×106 cells/ml) were stimulated with (A) 0.3 mg/ml GA or (B) 30 ng/ml
TNP-BSA in the absence or presence of 1 μM BKA or 0.3 mM apocynin, and O2
U− generation was measured by monitoring cytochrome c reduction (ΔOD540) using a microplate reader.
(C, D) Statistical analysis data of the ΔOD540 following 5 min of exposure to (C) GA or (D) TNP-BSA. The data represent the mean±SE of six independent experiments. The statistical
signiﬁcance versus GA stimulation in each fraction was determined using an unpaired Student's t-test. ⁎⁎pb0.01; ⁎⁎⁎pb0.001.
Fig. 9. GA induces O2
U− release from the mitochondria. RBL-2H3 cells (1×106/ml)
suspended in HBSSwere incubatedwith 5 μMMitoSOX Red for 15min at 37 °C. Then the
cells were stimulated with (A) 0.3 mg/ml GA or (B) 30 ng/ml TNP-BSA in the absence or
presence of 1 μM BKA or 0.3 mM apocynin at 37 °C and allowed to stand on ice
immediately. After centrifugation at 4 °C, the cells were analyzed for MitoSOX signal in a
ﬂow cytometer. The data are shown as F/F0, where F0 represents ﬂuorescence in
unstimulated cells and F is ﬂuorescence in stimulated cells, and represent mean±SE of
three independent experiments. The statistical signiﬁcance versus GA stimulation in
each fraction was determined using an unpaired Student's t-test. ⁎pb0.05.
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In the current study, we demonstrated that GA, an AGE provokes
mast cell death by apoptosis and that RAGE, an AGE-binding protein
mediates the pro-apoptotic activity. These ﬁndings are consistent with
the view that RAGE mediates AGE toxicity [8–13]. Moreover, we
demonstrated that activation of RAGE causes the mitochondrial death
pathway in which [Ca2+]m overload and release of mitochondrial O2
U−
may play critical roles. ROS have also been found to play roles in the
pathogenesis of diabetic complications, and normalization of mito-
chondrial ROS has been shown to prevent glucose-induced metabolic
abnormalities [41,42]. A number of studies have suggested that ROS
generation plays a role in AGE-induced apoptosis [41–45]. However,
the conclusions of most of these studies were solely based on ﬁndings
that various nonspeciﬁc antioxidants attenuate apoptosis without
direct measurement of ROS. As a result, the oxidant species involved
and their sources remain unidentiﬁed. On the other hand, a few
investigators have directly shown that AGE signaling leads to ROS
production, via mitochondria and NADPH oxidase [25,45,46].
Unfortunately however, these reports have provided no evidence
that the ROS examined did indeed mediate AGE toxicity. Our results
clearly show that GA-induced mast cell apoptosis was associated
with elevated O2
U− generation in mitochondria and release into the
extracellular ﬂuid. Furthermore, the cell-impermeable O2
U−-selective
scavenging enzyme SOD completely blocked the apoptosis,
indicating that extracellular O2
U− is a mediator of the pro-apoptotic
activity of GA. Our data are in accordance with an early report
indicating that activation of RAGE induces elevated O2
U− generation in
the mitochondria [45]. Another important ﬁnding in the current
study is that GA, but not TNP-BSA stimulation, induces O2
U− release
from mitochondria into the extracellular ﬂuid, although both stimuli
evoke O2
U− generation in the mitochondria. Given that GA, but not
TNP-BSA stimulation, induce substantial apoptosis, this ﬁnding
suggests that extracellular O2
U− release from mitochondria rather
Fig.10. Extracellular O2
U−mediates GA-inducedmast cell apoptosis. (A) RBL-2H3 cells grown in 24-well plates (5×105 cells/200 μl) were incubatedwith 0.3 mg/ml GA in the absence or
presence of 10 U/ml SOD for 18 h at 37 °C, and cell death was analyzed by annexin V/PI double-staining. The data were calculated as the percentages of annexin V-positive cell
populations relative to the whole cell population set at 100%, and represent the mean±SE of at least three independent experiments. (B) RBL-2H3 cells (3×106 cells/ml) were
stimulated with 0.3 mg/ml GA in the absence or presence of 10 U/ml SOD for 18 h at 37 °C. The cytochrome c contents in the cytosolic fractions were determined using an ELISA kit as
described in the legend to Fig. 7. The data represent the mean±SE of ﬁve independent experiments. (C) RBL-2H3 cells (3×106 cells/ml) were stimulated with 0.3 mg/ml GA at 37 °C in
the presence or absence of 10 U/ml SOD for 18 h at 37 °C. Next, caspase-3/7 activation and changes in the mitochondrial membrane potential were determined by ﬂow cytometry. The
data are representative of ﬁve independent experiments. (D) Rhod2-loaded cells (1×106 cells/ml) were treated with 10 U/ml SOD, and immediately stimulated with 0.3 mg/ml GA or
30 ng/ml TNP-BSA. Fluorescence was monitored for up to 3 min in a microplate ﬂuorometer. The data are shown as the increase in [Ca2+]m (Δ[Ca2+]m) and represent the mean±SE of
three independent experiments. The statistical signiﬁcance of differences versus GA stimulation alone was determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001.
Fig. 11. RAGE mediates GA-induced mitochondrial death pathway. (A) RBL-2H3 cells in 6-well plates (2.5×105 cells/well) or in 24-well plates (5.0×104 cells/well) were transfected
with siRNA for RAGE. As a negative control siRNA (Nega), a nontargeting scrambled siRNA with no sequence homology to any known gene sequences was used. The expression of
RAGE mRNA was measured using RT-PCR at 48 h after the transfection of siRNA. (B) Adherent RAGE knocked down (RAGE-KD) cells (which had been cultured for 48 h after siRNA
transfection in 24-well plates) or control cells were stimulatedwith 0.3 mg/ml GA for 18 h, and cell death was analyzed by annexin V/PI double-staining. (C) RAGE knocked down cells
or control cells (1×106 cells/ml) were stimulated with 0.3 mg/ml GA, and O2
U− generation was measured by monitoring cytochrome c reduction (ΔOD540) using a microplate reader.
Statistical analysis data of themaximal ΔOD540 following exposure to GAwere shown. The data represent themean±SE of three independent experiments. The statistical signiﬁcance
of differences was determined using an unpaired Student's t-test. ⁎⁎⁎pb0.001. (D) Rhod2-loaded RAGE knocked down cells or control cells (1×106 cells/ml) were stimulated with
0.3 mg/ml GA. Fluorescence was monitored for up to 3 min in a microplate ﬂuorometer. These above data are representative of three independent experiments.
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U− generation, is important for induction of
apoptosis. Since this O2
U− release was completely blocked by
bongkrekic acid, O2
U− seemed to be released via PTPs most likely
voltage-dependent anion channel.
Although oxidative stress has been proposed to play a role in AGE-
induced apoptosis, the mechanisms by which this stress mediates the
apoptosis are unclear. We demonstrated that extracellular O2
U−
mediates mitochondrial Ca2+ dysregulation, another biochemical
change associated with the induction of apoptosis in a number of
cell types [47–49]. Accumulating evidence indicates that, under
oxidative circumstances, mitochondrial Ca2+ accumulation can switch
from a physiological beneﬁcial process to a cell death signal. It has
been thought that maintenance of the mitochondrial redox status
and/ormitochondria Ca2+ homeostasis are essential for cell survival by
preventing the release of pro-apoptotic substances, such as cyto-
chrome c, from the mitochondria [47]. Opening of PTPs triggers the
release of pro-apoptotic proteins, including cytochrome c, from the
mitochondrial inter-membrane space into the cytoplasm, which
activates the caspase-dependent death pathway. Our data clearly
demonstrate that opening of PTPs is crucial for GA-induced mast cell
apoptosis and the upstream biochemical events, including mitochon-
drial cytochrome c release, caspase-3/7 activation, and mitochondrial
membrane potential reduction. Banki et al. [50] demonstrated that
mitochondrial hyperpolarization precedes the collapse the mitochon-
drial membrane potential. Given that GA is much more effective than
TNP-BSA in inducing apoptosis, GA is expected to evoke a higher
mitochondrial hyperpolarization, thereby causing the collapse of the
ΔΨm, resulting in the caspase-dependent execution of cell death. To
date unlike TNP-BSA stimulation, although we observed no repro-
ducible mitochondrial hyperpolarization after GA treatment for 18 h
by ﬂow cytometry, it is possible that the effect is observed earlier. We
are currently investigating the effect of GA on theΔΨm under different
conditions. Collectively, our data suggest that extracellular O2
U−
mediates GA-induced mitochondrial Ca2+ dysregulation, thereby
provoking the mitochondrial death pathway. Further studies to clarify
the mechanisms by which extracellular O2
U− affects mitochondrial Ca2+
homeostasis are underway.
In conclusion, we have presented evidence that mast cells are
cellular targets of AGE toxicity and that mitochondria-derived
extracellular O2
U− mediates the pro-apoptotic activity via mitochon-
drial Ca2+ dysregulation. These pieces of evidence support the view
that AGE may modulate mast cell survival. Given that mast cells act as
conductors of allergic and inﬂammatory reactions and play roles in
innate and acquired immunity, AGE-induced mast cell death may be
relevant to the altered immunological and inﬂammatory responses.
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